Publications by authors named "Setsuaki Annen"
J Nippon Med Sch
February 2023
Article Synopsis
- Three categories of biologics—TNF inhibitors, IL-17 inhibitors, and IL-23 inhibitors—are used to treat severe psoriasis, with recent research highlighting the relevance of specific lab biomarkers (like NLR, PLR, MLR, and CRP) in determining disease severity.
- A study involving 67 patients assessed the relationship between these biomarkers and disease activity, using a statistical model to link lab results with the psoriasis area and severity index (PASI) scores.
- Results showed that both CRP and NLR were significantly correlated with PASI scores in all patients, with NLR emerging as the most consistent biomarker, particularly effective in patients treated with IL-17 inhibitors.
